Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
135.9 EUR | -0.66% |
|
-1.10% | -3.46% |
07-02 | J&J: promising results in multiple myeloma | CF |
07-02 | Johnson & Johnson Says Interim Analysis of Blood Cancer Therapy Study Show Promise | MT |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock
- News Johnson & Johnson